Top Small Cap Stocks To Buy For 2018

Small cap health and wellness and Cannabidiol (CBD) stock Gridiron BioNutrients (OTC: GMVP) is getting some extra celebrity attention as the Company is sponsoring a Hole at the annual NFL Alumni Celebrity Gold Classic – a Super Bowl of Golf qualifying tournament as the winning team will represent the NFL Alumni Pro Bowl tournament at the 2018 Super Bowl of Golf at TPC Las Vegas in Las Vegas. The tournament is going on right now until 3 PM withgroups of four paired with a celebrity captain to compete in a team scramble tournament

Gridiron BioNutrients is anutraceutical innovator specializing in cannabidiol health health and wellness products that was founded by Darren Long, a former NFL tight-end and 3x All American College Football Player who became an advocate of health and proper nutrition as a result of the symptoms from Chronic Traumatic Encephalopathy (CTE) or brain concussions. Current innovative CBD products include Gridiron MVP water, Gridiron MVP concentrate, Gridiron CBD H2O Probiotics water, Gridiron Premium Hemp Salve, Gridiron Premium Hemp Oil and Gridiron Premium Hemp Oil Capsules plus there are plans to roll-out additional products over the next twelve months.

Top Small Cap Stocks To Buy For 2018: Panera Bread Company(PNRA)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Keurigs plight (actually, JABs) is worsening, with the K-cup market slowing to almost no growth now, and Keurig continuing to lose own brands share. Starbucks (SBUX) echoed the notion of a K-cup market slowdown at its seminar on Wednesday (and is guiding for its [consumer packaged goods, or CPG,] growth below recent trends), but it expects to increase its share of total CPG coffee to 20% from 15%. Come early February it will be a year since the closing of the Keurig deal for JAB Holdings. The pressure on JAB is more significant if we take into account the high leverage of the deal (JAB contributed one fourth of the $12Bn price tag). It is a tough predicament. On the one hand we argue that to make that deal work, they need to buy more (own) brands either from the retail channel (that can be extended to CPG: Dunkin (DNKN)? Panera (PNRA)?), or outright buy CPG brands (like the entire Kraft Heinz portfolio, and or Tata Groups Eight OClock brand). But can/how do they fund these deals? Maybe Mars and Warren Buffett (Mars is involved in office coffee with Starbucks), private equity, and or 3G can help? While this note is not about Positive-rated Mondelez, we have mentioned before a scenario where Kraft Heinz buys Mondelez and partly funds the deal by selling its own CPG coffee business (~$3Bn we say) to JAB as well as divests the Mondelez 20% plus stakes in Keurig (North America) and Jacobs Douwe Egberts (Western Europe), which together at this stage are worth ~$7-8Bn. But, yes, JAB will need deep-pocket partners and generous lenders. Net, JAB needs to do something soon.

  • [By Seth McNew]

    Other companies have followed suit with great success, including PaneraBread (NASDAQ:PNRA), which has focused on improving the customer experience, including via shorter wait times. Panera 2.0 was largely successful because of the company’s focus on its digital strategy and Chipotle looks to be doing the same thing.

  • [By Billy Duberstein]

    In late March, the company informed investors that after a two-year undertaking, it had finally removed all preservatives from its tortillas, making the Chipotle menu completely preservative-free. The company also called out competitors McDonald’s (NYSE: MCD) and Panera Bread (NASDAQ: PNRA) for marketing their menus as “natural,” as Chipotle insisted these other restaurants still use preservatives made in a lab.

Top Small Cap Stocks To Buy For 2018: FuelCell Energy Inc.(FCEL)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Plug Power plus alternative energy or fuel cell stock peers like Ballard Power Systems Inc (NASDAQ: BLDP), FuelCell Energy Inc (NASDAQ: FCEL) and Hydrogenics Corporation (NASDAQ: HYGS) all peaking in 2014 before collapsing with shares leveling off or perhaps finally to recover a bit:

  • [By Logan Wallace]

    FuelCell Energy (NASDAQ: FCEL) and HRG Group (NYSE:HRG) are both oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

  • [By Peter Graham]

    The Q1 2017 earnings report for small cap fuel cell stockFuelCell Energy Inc (NASDAQ: FCEL) is scheduled forbefore the marketopens onThursday (March 9th). Last December,FuelCell Energy announced a business restructuring to reduce costs and align production levels with current levels of demand in a manner that is consistent with the Companys long-term strategic plan.The Company said it cut 96 jobs, or 17% of its workforce, and has halved production to 25 megawatts a year in order to position for delays in order flow.

  • [By Peter Graham]

    A long term performance chart shows shares of Plug Power along withalternative energy or fuel cell stock peers like Ballard Power Systems Inc (NASDAQ: BLDP), FuelCell Energy Inc (NASDAQ: FCEL) and Hydrogenics Corporation (NASDAQ: HYGS) all peaking in 2014 with shares leveling off or just sliding downward moderately over the past year:

Top Small Cap Stocks To Buy For 2018: Rackspace Hosting Inc(RAX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Rackspace Hosting, Inc. (NYSE: RAX) reported better-than-expected earnings for the first quarter, but the company missed analysts’ sales estimates. Rackspace shares dropped 7.72 percent to $20.80 in the after-hours trading session.

Top Small Cap Stocks To Buy For 2018: China Metro-Rural Holdings Limited(CNR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

  • [By Max Byerly]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

Top Small Cap Stocks To Buy For 2018: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We updated our annual U.S. Hep C survey in early July, in order to gauge the future for Gilead, AbbVie/Enanta Pharmaceuticals (ENTA), Merck, and J&J/Achillion Pharmaceuticals (ACHN). In conjunction with script trends, physicians indicate that the market for treatment-eligible, easily accessible Hep C patients is shrinking, but that Gilead’s share of the shrinking pie is continuing to grow. With no end to script declines in sight, we are left wondering where the Hep C will bottom…

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) dropped about 6.9% Friday to post a new 52-week low of $2.69 after closing at $2.89 on Thursday. The 52-week high is $5.66. Volume was around 6.2 million, more than three times the daily average of around 1.9 million. The company had no specific news.

Leave a Reply

Your email address will not be published. Required fields are marked *